Jul. 12 at 4:09 PM
$SPRO I just opened a position yesterday after watching this story unfold, GSK stopped the trial early as efficacy was good, as we know the stock had a great day. I have followed this stock for several years and am only seeing a Buyout price of 5 to 7 Dollars maximum and definitely looking for a realistic valuation based on all that I have read.
The company SPRO, will receive 25 million dollars upon the filing of the NDA from GSK and that should be in this half of the year. As far as the other drugs in SPRO’s pipeline, they don’t have much value since the efficacy of the drug wasn’t good, so a company would have to correct that and then go from there. I would like a buyout from GSK but I don’t see them pulling the trigger quite yet, but retail is always the last to know and usually dumb money 💰
